Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics—a diagnosis and treatment approach based on the combination of medical imaging ...
Cancer kills more than half a million men, women, and children each year in the U.S, and chemotherapy is only slightly more discriminating than the disease it treats. As a result, many cancer treatments kill cells throughout ...
Engineered T cell immunotherapy, such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy, has emerged as a potent therapeutic strategy for treating tumors.
The dark skin pigment melanin protects against the sun's damaging rays by absorbing light energy and converting it to heat. This could make it a very effective tool in tumor diagnosis and treatment, as demonstrated by a team ...
New photonic tools for medical imaging can be used to understand the nonlinear behavior of laser light in human blood for theranostic applications. When light enters biological fluids it is quickly scattered, however, some ...
A team of researchers from New York University has engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging (MRI).
Nanoparticles can be used as substrates for computation, with algorithmic and autonomous control of their unique properties. However, scalable architecture to form nanoparticle-based computing systems is lacking at present. ...
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their combined effect appeared to be 2,200 times stronger compared to that exerted by the radiation ...
Nanosystems that deliver anticancer drugs or imaging materials to tumours are showing significant progress, particularly those that respond to tumour-related stimuli, according to a review published in the journal Science ...
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.
